Office of the Vice President for Research
Northern Arizona University PO Box 4087 Flagstaff, AZ 86011-4087
928-523-4340 928-523-1075 fax www.research.nau.edu
Great minds don't think alike. If they did, the Patent Office would only have about fifty inventions. —Scott Adams Dear Colleagues, Welcome to Northern Arizona University’s Intellectual Property Portfolio. Within these “covers” you will find an evolving and dynamic collection of innovations that represent the desire and willingness of NAU faculty and staff to contribute to the global body of knowledge while discovering solutions to real-world problems. These inventions are generally available for licensing by both established and start-up companies, and we also welcome the opportunity to enter into research partnerships with companies interested in sponsoring further R&D on these inventions or with the specific researchers. NAU Innovations is a catalytic organization created to develop and promote NAU’s intellectual property holdings, with a mission to create value for the public by offering high quality opportunities to the private sector. The technologies featured here are anticipated to grow into viable commercial products and services for the benefit of all. Please contact us at NAUInnovations@nau.edu or 928-523-8288 to learn more about our offerings and to discuss how you can become one of Northern Arizona University’s partners in innovation. Sincerely,
Lesley K. Cephas Director, NAU Innovations
William Grabe, Ph.D.
Vice President for Research
Lesley K. Cephas
Director of Research Development and Technology Transfer
NAU Innovations
PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
4
Available Technologies Please select the side arrow to browse our IP available for licensing, or select a link below:
System and Software for optimizing Energy Efficiency in Programmable Devices Vaccine against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms Rapid Diagnostic Assay for Methicillin-Resistant Staphylococcus aureus (MRSA) Functionalized Paramagnetic Particles for In vivo diagnosis of MRSA Biofilms Structural Supercapacitors Graphene-based Synthetic Leaves for Passive Water Pumping, Cooling, and Humidification Human Isoprenoid Pathway Inhibitors as Novel Antibiotic Adjuvants Shareview: Leveraging Mobile Devices for Rich Social Media Sharing TAXISS: Cross-Species Molecular Sensors for Environmental Analysis 3-D Imaging and Pattern Matching Algorithms for Firearms and Toolmarks Identification
System and Software for Optimizing Energy Efficiency in Programmable Devices Inventor Dr. Paul Flikkema Professor Electrical Engineering
Invention Description This invention describes a programmed machine that, during the course of its operations, optimizes its energy efficiency. The invention provides an electronic circuit for sensing of power use and a means of controlling a sequence of register values, establishing the machine’s power-use configuration, along with a means to minimize energy use. In practice, this technology describes a hardware/software extension for embedded systems that are found in a variety of electronically controlled devices including appliances and consumer electronics. This extension monitors energy use and continuously adjusts system parameters in an attempt to improve energy efficiency. The process is undertaken autonomously, freeing the designer from the task of hand-optimizing system performance. The system is implemented as a software library under a portable application programming interface (API), which allows it to be used with a variety of heterogeneous devices, presenting an abstracted hardware interface to the application code. This system may find applications in low-power embedded computing systems, such as those required to support the emerging Internet of Things.
Intellectual Property Status: Patent Pending
Licensing Status:
Potential Applications
Benefits and Advantages
Instruments for industrial process control manufacturing
Frees the programmer from handoptimizing energy usage and maintains energy optimization throughout unforeseen usage conditions.
Available
Wireless sensor networks
Contact
Implementation in consumer electronics
Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
5
Handles the details of energyoptimization and presents a clean interface to the application programmer. Provides rich information regarding energy usage of particular peripherals.
Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms Inventors
Invention Description According to the Centers for Disease Control and Prevention, over 62,000 cases of MRSA infection were reported in 2011, with the vast majority affecting individuals over the age of 65. A joint research project between investigators at NAU and the University of Maryland - Baltimore has produced a vaccine for MRSA biofilms. This quad-valent vaccine, when supplemented with vancomycin treatment, clears a significantly greater amount of the infection than with the standard treatment using vancomycin alone. This is due to the selection of antigens expressed at high levels in the various stages of biofilm development. In contrast, current vaccines in development have selected antigens expressed during the pre-biofilm stage, and do not cover the morphological and antigenic changes that occur during biofilm development. In combination with the lateral flow diagnostic assay (see portfolio page 11, and the ability to detect MRSA infections in vivo (see portfolio page 12, this trio of inventions provides the ability to detect, localize, and prevent MRSA –related biofilm infections. MRSA from NAU News-Centers for Disease Control and Prevention
Dr. Jeff Leid Associate Professor Biological Sciences Dr. Mark Shirtliff Associate Professor University of Maryland, Baltimore School of Dentistry
Intellectual Property Status: Patent Pending
Potential Applications
Benefits and Advantages
Prevention of hospital-acquired infections
Clears more of the infection than with standard treatment
Medical implant surgery patient monitoring
Covers the morphological and antigenic changes that occur during biofilm development
MRSA infection prevention and treatment
Licensing Status: Available
Contact Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
6
Rapid Diagnostic Assay for MethicillinResistant Staphylococcus aureus (MRSA) Inventors Dr. Jeff Leid Associate Professor Biological Sciences Dr. Timothy L. Vail Adjunct Professor Chemistry & Biochemistry Dr. Mark Shirtliff Associate Professor University of Maryland, Baltimore School of Dentistry
Invention Description The Numbers: More than 126,000 patients hospitalized in the U.S. are infected with MRSA (methecillin-resistant Staphylococcus aureus) annually, leading to over 5,000 deaths, increased length of hospital stays, and significantly higher healthcare costs. The Problem: A major hurdle to the success of diagnosing and treating a MRSA biofilm infection is the successful localization and targeting of biofilm infections in vivo. Moreover, MRSA infections are notoriously difficult to treat, as they are often associated with implanted medical devices such as artificial heart valves, catheters, and stents. Rapid diagnosis is critical to effective treatment. This patent- issued assay provides that diagnosis in ten minutes or less. The Solution: Researchers at NAU and the University of Maryland have developed a new diagnostic assay to provide clinicians with a rapid, inexpensive and sensitive tool for early diagnosis of MRSA infections. As a stand-alone device, it can be “inventoried� to an existing commercial diagnostics portfolio, or provide rapid revenue for a start-up company to build its diagnostics base. This is likely to be a CLIA-waived device, making regulatory hurdles minimal.
Intellectual Property Status: US Patent 8,541,006 MRSA assay: Courtesy of Jennifer Kofonow
Licensing Status: Available
Contact Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
7
Potential Applications
Benefits and Advantages
Diagnosis of hospital-acquired infections
Distinguishes attached biofilm infections (e.g. endocarditis) from systemic infections
Medical implant surgery patient monitoring MRSA infection prevention and diagnosis
Allows rapid patient monitoring of medical device implant surgery preand post-operative Can be read visually with no need for expensive diagnostic equipment
Functionalized Paramagnetic Particles for In vivo Diagnosis of MRSA Biofilms Inventors
Invention Description Biofilms are attached communities of microorganisms that are inherently resistant to antibiotics and killing from the human immune system. These communities are often associated with indwelling medical devices such as catheters, endotracheal tubes, surgical sutures, hip and knee joint prostheses and dental implants. However, biofilms also colonize heart valves (endocarditis), bone (osteomyelitis), tooth surfaces (dental caries), gums (periodontal disease), burn patients and the lungs of cystic fibrosis patients. In all cases, these infections dramatically increase morbidity and mortality costing an estimated $20 billion dollars annually. The CDC estimates that of all nosocomial infections, >70% are caused by biofilms. In conjunction with the diagnosis of, and vaccination against MRSA biofilm infections, a joint research project between investigators at NAU and the University of Maryland - Baltimore has produced an in vivo detection method for MRSA biofilm infections. These infections are often associated with endocarditis or osteomyelitis, and can be localized at or near medical device implants, such as catheters, heart valves, or stents. The inventors have successfully detected S. aureus biofilms on infected tibial pins whereas implanted sterile pins showed no sign of biofilm development. Specific visualization of the site of biofilm infection will give surgeons the exact site of infection leading to removal of less healthy tissue and more biofilm infection. Specific targeting of the biofilm would also allow for specific delivery of a well-defined quantity of chemotherapeutic agents that may then be effective against the biofilm-mode of growth.
Dr. Jeff Leid Associate Professor Biological Sciences Dr. Timothy L. Vail Adjunct Professor Chemistry & Biochemistry Dr. Mark Shirtliff Associate Professor University of Maryland, Baltimore School of Dentistry
Intellectual Property Status: US Patent 8,697,375
Licensing Status: Potential Applications
Benefits and Advantages
Prevention of hospital-acquired infections
Early diagnosis
Medical implant surgery patient monitoring MRSA infection prevention and treatment
Minimizes removal of healthy tissue surrounding an infection
Available
Contact Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
8
Structural Supercapacitors Inventors Dr. Constantin Ciocanel Assistant Professor Mechanical Engineering Dr. Cindy Browder Associate Professor Chemistry & Biochemistry
Invention Description NAU researchers have developed a solid polymer electrolyte resin that interfaces with carbon fiber stacks to create a structural supercapacitor—a carbon fiber based composite material suitable for high-performance applications (such as aerospace components, medical devices, wind turbines, etc.), adding power storage capability without compromising the strength and durability of the material. The structural supercapacitor has morphology similar to that of an electric double layer capacitor (EDLC), and in addition to storing electrical charge will be able to withstand mechanical loading, making it suitable for building structures with added power storage capability. Using our specific formulation of the solid polymer electrolyte, specific capacitance of 1.4kF/m3 and leakage resistance of 380kΊ has been achieved.
Intellectual Property Status:
Photos Courtesy of Dr. Constantin Ciocanel
Patent Pending
Licensing Status: Available
Contact Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
9
Potential Applications
Benefits and Advantages
Structurally integrated actuators for medical devices such as prosthetic limbs
Added power storage capability by using structural material.
Battery-free electrical windpowered generators or electric vehicles Multifunctional lightweight aviation and aerospace components Lightweight handheld devices such as calculators, cell phones, and GPS units
Moldable polymer matrix provides support for device manufacture. No compromise to strength and durability of structure Reduced power consumption, device size, the number of required components, and can be made into virtually any required shape
Graphene-based Synthetic Leaves for Passive Water Pumping, Cooling, and Humidification Inventors
Invention Description Tree leaves and graphene oxide thin films both have amazing properties. When water evaporates from the surface of a leaf, more water is drawn into the leaf, and the leaf acts as a miniature water pump. Also, when water evaporates from leaves, the surrounding air becomes cooler. Leaves act as air conditioners. Graphene oxide (GO) thin films allow water to flow through them easily, while helium and other substances cannot.
NAU researchers are combining the novel properties of leaves and GO films in the form of synthetic tree leaves.
Dr. Eric Morgan Postdoctoral Scholar Institute for Sustainable Energy Solutions Dr. Thomas Acker Professor Mechanical Engineering Dr. George Koch Professor Biological Sciences
This technology will allow the realization of solar –powered water lines that can both filter and move water to great heights without a mechanical pump, and air conditioning systems capable of cooling and humidifying entire buildings with little to no energy from the power grid.
Graphene Oxide Thin Film Š Nanotechweb.org
Potential Applications
Benefits and Advantages
Lifting water from an aquifer without using a mechanical pump
Providing clean water to developing countries at minimal energy cost
Passive air conditioning systems for residential and commercial buildings
Providing low energy cost air conditioning through evaporative cooling
Low-Energy access to clean water of an aquifer in developing countries
Significant energy savings in urban environments Low cost of maintenance due to a lack of moving parts
Intellectual Property Status: Patent Pending
Licensing Status: Available
Contact Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
10
Human Isoprenoid Pathway Inhibitors as Novel Antibiotic Adjuvants Inventors Dr. Nathan Nieto Assistant Professor Biological Sciences Dr. Andrew Koppisch Associate Professor Chemistry & Biochemistry
Invention Description Boosting the effectiveness of an antibiotic is a critical component in the fight against infectious disease. This technology is based on the ability to exploit a microorganism’s metabolic pathways to make them more susceptible to standard antibiotics. It has been shown that disrupting the biosynthetic pathway of isoprenoids (compounds related to cholesterol synthesis) in microorganisms makes them more susceptible to antibiotic treatment. This adjuvant therapy may provide a means to reduce the over-use of antibiotics that has led to the evolution of antibiotic-resistant bacterial strains.
Intellectual Property Status: Early Stage
Licensing Status: Available
Contact Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
11
Ixodes pacificus nymph, a tick vector of bacterial disease. Magnified 59X. Courtesy of Dr. Nathan Nieto.
Potential Applications
Benefits and Advantages
Medical infectious disease therapy for recalcitrant infections such as Lyme disease or MRSA
May provide a new weapon to fight infections by increasing microbial susceptibility to antibiotics
Auxiliary treatment for veterinary antibiotic regimens to lower levels of antibiotics used in animals for dairy and meat consumption
May lower overall treatment costs by lowering required dosages of antibiotics Relatively low regulatory hurdles: several drugs that affect the isoprenoid biosynthesis pathway in humans are already FDA- approved
Shareview: Leveraging Mobile Devices for Rich Social Media Sharing Inventor
Invention Description Shareview is an integrated system of hardware and software aimed at capturing, sharing, and viewing point-of-view audiovisual content in real time. This patent-pending system uses an over-the-ear Bluetooth ® enabled device to capture streaming video and audio from the user’s point-of-view, and combines it with a mobile phone app to upload the captured data to the Shareview servers to associate the video with the user’s account. The content is made available on the Shareview service as a real-time stream (a “view”). Users have full editorial and security management options over the degree to which any or all of their shares are accessible to others. A content channel, which allows conceptual groupings of shares with similar thematic content and access privileges (such as sporting event views), is integral to the sharing mechanism. Shareview will also support notifications, so that users can register their interest in specific channels and receive notifications if a new “share” becomes available in any of their registered channels. This system will focus on real-time streams of content, not recorded content: only four hours of content will be stored per share.
Potential Applications
Benefits and Advantages
Real-time video and audio that can be used by friends and family to share their life experiences
Enhanced global experience sharing among focused interest groups
Education and distance learning
Enhanced law enforcement, quality control operations, or other verifiable experience capture and recall, thus relieving the user of notebook recording, or other recallintensive procedures
Law enforcement and social services The creation of reality entertainment programming that does not demand the production overhead customary to this type of content
Dr. John Georgas Postdoctoral Scholar Institute for Sustainable Energy Solutions
Intellectual Property Status: Patent Pending
Licensing Status: Available
Contact Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
12
TAXISS: Cross-Species Molecular Sensors for Environmental Analysis Inventors Dr. Catherine R. Propper Professor Biological Sciences Dr. Caren Helbing Professor Biochemistry & Microbiology University of Victoria, British Columbia Dr. Nicholas Veldhoen Biochemistry & Microbiology University of Victoria, British Columbia
Invention Description Amphibians are sentinel organisms that are highly sensitive to changes in their environment, including exposure to increased pollutants and other stressors. This invention presents an innovation that relies upon a gene expression readout for detecting thyroid hormone disrupting activities using anuran (frog or toad) species as model organisms. This is a significant improvement over the standard frog tadpole metamorphosis assay. It provides greater predictive value and applicability to both laboratory testing and field applications across a range of all frog sentinel species. These species include those commonly used in laboratory studies for developmental and/or toxicity testing, as well as sentinel species used for environmental toxicology or ecological assessment. The use of these primer sets provides a simple, low-cost solution to the issue of cross-species comparison of responses and sensitivities.
Intellectual Property Status: Patent Pending
ŠDr. Laurent Sachs
Potential Applications
Benefits and Advantages
Contact
Environmental monitoring of complex mixtures such as municipal wastewater and aquatic ecosystems
Highly conserved primer sets screen the same genes found in many species
Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011
Toxicological testing of pharmaceuticals and other chemicals for thyroid hormone disruption
928-523-2088
Developmental biology research
Licensing Status: Available
NAUInnovations@nau.edu
13
Simple and low-cost comparisons using quantitative PCR Validated primer sets for “normalizer� genes provide internal reference standards
3-D Imaging and Pattern Matching Algorithms for Firearms and Toolmarks Identification Invention Description The science and technology of forensics and crime scene investigation has been growing rapidly in recent years. Along with DNA evidence, the ability to validate scientifically the evidence that connects a weapon or bullet casing to a crime scene can be a critical determinant in the legal process. Currently, a tedious and costly process of visual microscopic comparisons is performed. This technology is a robust and cost effective imaging system that provides high-speed, quantitative 3-dimensional topological measurements of ballistics cartridge casings. Consisting of two components, this technology combines an imaging system with data-rich 3D pattern matching algorithms that will automate ballistics identification with high precision and accuracy. This may be developed into a bench-top system that can be further developed into a field portable system for on-site use by crime scene forensics experts.
Inventor Dr. Christopher Mann Assistant Professor Physics and Astronomy
Intellectual Property Status: Early Stage High resolution 3D image Captured from a 9 mm Bullet Casing Courtesy of Dr. Christopher Mann
Potential Applications Crime Scene Investigation Litigation proceeding and expert witness testimony Development of a national or international database of ballistics identification information
Benefits and Advantages High Speed 3-dimensional imaging and processing Increased precision and accuracy of ballistics toolmark identification processes Digitized information adds statistical robustness and reduces human error associated with the legal process
Licensing Status: Available
Contact Dr. Angela Yamauchi NAU Innovations PO Box 4087 Flagstaff, AZ 86011 928-523-2088 NAUInnovations@nau.edu
14